150 related articles for article (PubMed ID: 24419641)
1. Pancytopenia secondary to cytomegalovirus reactivation.
Tse JR; Ng GX
BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24419641
[TBL] [Abstract][Full Text] [Related]
2. Pancytopenia with hypercellular bone marrow secondary to cytomegalovirus after cardiac transplant.
Elkhateeb O; Jackson S; Schlech WF; Storm K; Howlett J
J Heart Lung Transplant; 2009 Jul; 28(7):749-50. PubMed ID: 19560708
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir.
Laurenti L; Piccioni P; Cattani P; Cingolani A; Efremov D; Chiusolo P; Tarnani M; Fadda G; Sica S; Leone G
Haematologica; 2004 Oct; 89(10):1248-52. PubMed ID: 15477211
[TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant cytomegalovirus infection in a patient with granulomatosis with polyangiitis during immunosuppressive treatment.
Piccirilli G; Chiereghin A; Maritati M; Turello G; Felici S; La Corte R; Gabrielli L; Contini C; Lazzarotto T
Antivir Ther; 2020; 25(2):111-114. PubMed ID: 32297594
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Esophageal Cancer in a Patient with CMV Reactivation after Neoadjuvant Chemoradiation Therapy].
Megumi K; Okumura H; Shimonosono M; Ijichi T; Uchikado Y; Omoto I; Yo H; Kita Y; Uenosono Y; Arigami T; Mori S; Baba K; Ishigami S; Owaki T; Natsugoe S
Gan To Kagaku Ryoho; 2015 Oct; 42(10):1307-9. PubMed ID: 26489581
[TBL] [Abstract][Full Text] [Related]
6. [Cytomegalovirus meningoencephalitis in a diffuse large B-cell lymphoma patient undergoing salvage chemotherapy].
Yoshida K; Kosako H; Yamashita Y; Kobata H; Oiwa T; Hosoi H; Murata S; Mushino T; Nishikawa A; Araoka H; Sonoki T; Tamura S
Rinsho Ketsueki; 2019; 60(2):124-129. PubMed ID: 30842379
[TBL] [Abstract][Full Text] [Related]
7. Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation.
Park GE; Ki HK; Ko JH
BMC Infect Dis; 2021 May; 21(1):414. PubMed ID: 33947335
[TBL] [Abstract][Full Text] [Related]
8. Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission.
Yoon JH; Lee S; Kim HJ; Jeon YW; Lee SE; Cho BS; Lee DG; Eom KS; Kim YJ; Min CK; Cho SG; Min WS; Lee JW
Oncotarget; 2016 Mar; 7(13):17230-41. PubMed ID: 26883100
[TBL] [Abstract][Full Text] [Related]
9. Severe cytomegalovirus infection in a second kidney transplant recipient treated with ganciclovir, leflunomide, and immunoglobulins, with complications including seizures, acute HCV infection, drug-induced pancytopenia, diabetes, cholangitis, and multi-organ failure with fatal outcome: a case report.
Miszewska-Szyszkowska D; Mikołajczyk N; Komuda-Leszek E; Wieczorek-Godlewska R; Świder R; Dęborska-Materkowska D; Szmidt J; Durlik M
Ann Transplant; 2015 Mar; 20():169-74. PubMed ID: 25813912
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis.
Clos-Parals A; Rodríguez-Martínez P; Cañete F; Mañosa M; Ruiz-Cerulla A; José Paúles M; Llaó J; Gordillo J; Fumagalli C; Garcia-Planella E; Ojanguren I; Cabré E; Guardiola J; Domènech E
J Crohns Colitis; 2019 Mar; 13(3):385-388. PubMed ID: 30346606
[TBL] [Abstract][Full Text] [Related]
11. Rapid T cell repopulation after rabbit anti-thymocyte globulin (rATG) treatment is driven mainly by cytomegalovirus.
Havenith SH; Remmerswaal EB; Bemelman FJ; Yong SL; van Donselaar-van der Pant KA; van Lier RA; Ten Berge IJ
Clin Exp Immunol; 2012 Sep; 169(3):292-301. PubMed ID: 22861369
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study.
Kim YS; Kim YH; Kim JS; Jeong SY; Park SJ; Cheon JH; Ye BD; Jung SA; Park YS; Choi CH; Kim KO; Jang BI; Han DS; Yang SK; Kim WH
Gut Liver; 2014 Nov; 8(6):643-7. PubMed ID: 25368753
[TBL] [Abstract][Full Text] [Related]
13. Development of cytomegalovirus resistance to ganciclovir after oral maintenance treatment in a renal transplant recipient.
Bienvenu B; Thervet E; Bedrossian J; Scieux C; Mazeron MC; Thouvenot D; Legendre C
Transplantation; 2000 Jan; 69(1):182-4. PubMed ID: 10653401
[TBL] [Abstract][Full Text] [Related]
14. Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial.
Limaye AP; Stapleton RD; Peng L; Gunn SR; Kimball LE; Hyzy R; Exline MC; Files DC; Morris PE; Frankel SK; Mikkelsen ME; Hite D; Enfield KB; Steingrub J; O'Brien J; Parsons PE; Cuschieri J; Wunderink RG; Hotchkin DL; Chen YQ; Rubenfeld GD; Boeckh M
JAMA; 2017 Aug; 318(8):731-740. PubMed ID: 28829877
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.
Pillet S; Pozzetto B; Roblin X
World J Gastroenterol; 2016 Feb; 22(6):2030-45. PubMed ID: 26877608
[TBL] [Abstract][Full Text] [Related]
16. Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab.
Cheung WW; Hwang GY; Tse E; Kwong YL
Haematologica; 2006 May; 91(5 Suppl):ECR13. PubMed ID: 16709521
[TBL] [Abstract][Full Text] [Related]
17. The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease.
Delvincourt M; Lopez A; Pillet S; Bourrier A; Seksik P; Cosnes J; Carrat F; Gozlan J; Beaugerie L; Roblin X; Peyrin-Biroulet L; Sokol H
Aliment Pharmacol Ther; 2014 Apr; 39(7):712-20. PubMed ID: 24506221
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of cytomegalovirus reactivation in bone marrow transplant recipients by real-time PCR.
Ghaffari SH; Obeidi N; Dehghan M; Alimoghaddam K; Gharehbaghian A; Ghavamzadeh A
Pathol Oncol Res; 2008 Dec; 14(4):399-409. PubMed ID: 18392952
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation.
Ng AP; Worth L; Chen L; Seymour JF; Prince HM; Slavin M; Thursky K
Haematologica; 2005 Dec; 90(12):1672-9. PubMed ID: 16330442
[TBL] [Abstract][Full Text] [Related]
20. Initial cytomegalovirus prophylaxis with ganciclovir: no guarantee for prevention of late serious manifestations of CMV after solid organ transplantation.
Zandberg M; de Maar EF; Hofker HS; Homan van der Heide JJ; Rosati S; van Son WJ
Neth J Med; 2005 Nov; 63(10):408-12. PubMed ID: 16301763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
